Covid-19 Impact on Recombinant Vaccines Market, Global Research Reports 2020-2021

Code: QYRE-Auto-1R2950

Report

May 2020

Pages:99

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Merck& Co. Inc

Green Cross Corporation

Pfizer Inc

Bayer

Sanofi

Protein Science Corporation

This report covers market size and forecasts of Recombinant Vaccines, including the following market information:

Global Recombinant Vaccines Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global Recombinant Vaccines Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global Recombinant Vaccines Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global Recombinant Vaccines Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

Key market players

Major competitors identified in this market include Merck & Co., Inc, Green Cross Corporation, Pfizer Inc., Bayer AG, Sanofi S A., Protein Science Corporation, GlaxoSmithKline Plc., Novartis AG, Bharat Biotech, etc.

Based on the Region:

Asia-Pacific (China, Japan, South Korea, India and ASEAN)

North America (US and Canada)

Europe (Germany, France, UK and Italy)

Rest of World (Latin America, Middle East & Africa)

Based on the Type:

Subunit Recombinant Vaccines

Attenuated Recombinant Vaccines

Vector Recombinant Vaccines

Based on the Application:

Recombinant Human Vaccines

Animal Recombinant Vaccines

FEATURED COMPANIES

Merck& Co. Inc

Green Cross Corporation

Pfizer Inc

Bayer

Sanofi

Protein Science Corporation

1.1 Research Scope

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Recombinant Vaccines Industry

1.7 COVID-19 Impact: Recombinant Vaccines Market Trends

2 Global Recombinant Vaccines Quarterly Market Size Analysis

2.1 Recombinant Vaccines Business Impact Assessment - COVID-19

2.1.1 Global Recombinant Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Recombinant Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Recombinant Vaccines Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Recombinant Vaccines Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Recombinant Vaccines Factory Price by Manufacturers

3.3 Location of Key Manufacturers Recombinant Vaccines Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Recombinant Vaccines Market

3.5 Key Manufacturers Recombinant Vaccines Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Recombinant Vaccines Segments, By Type

4.1 Introduction

1.4.1 Subunit Recombinant Vaccines

1.4.2 Attenuated Recombinant Vaccines

1.4.3 Vector Recombinant Vaccines

4.2 By Type, Global Recombinant Vaccines Market Size, 2019-2021

4.2.1 By Type, Global Recombinant Vaccines Market Size by Type, 2020-2021

4.2.2 By Type, Global Recombinant Vaccines Price, 2020-2021

5 Impact of Covid-19 on Recombinant Vaccines Segments, By Application

5.1 Overview

5.5.1 Recombinant Human Vaccines

5.5.2 Animal Recombinant Vaccines

5.2 By Application, Global Recombinant Vaccines Market Size, 2019-2021

5.2.1 By Application, Global Recombinant Vaccines Market Size by Application, 2019-2021

5.2.2 By Application, Global Recombinant Vaccines Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Merck & Co., Inc

7.1.1 Merck & Co., Inc Business Overview

7.1.2 Merck & Co., Inc Recombinant Vaccines Quarterly Production and Revenue, 2020

7.1.3 Merck & Co., Inc Recombinant Vaccines Product Introduction

7.1.4 Merck & Co., Inc Response to COVID-19 and Related Developments

7.2 Green Cross Corporation

7.2.1 Green Cross Corporation Business Overview

7.2.2 Green Cross Corporation Recombinant Vaccines Quarterly Production and Revenue, 2020

7.2.3 Green Cross Corporation Recombinant Vaccines Product Introduction

7.2.4 Green Cross Corporation Response to COVID-19 and Related Developments

7.3 Pfizer Inc.

7.3.1 Pfizer Inc. Business Overview

7.3.2 Pfizer Inc. Recombinant Vaccines Quarterly Production and Revenue, 2020

7.3.3 Pfizer Inc. Recombinant Vaccines Product Introduction

7.3.4 Pfizer Inc. Response to COVID-19 and Related Developments

7.4 Bayer AG

7.4.1 Bayer AG Business Overview

7.4.2 Bayer AG Recombinant Vaccines Quarterly Production and Revenue, 2020

7.4.3 Bayer AG Recombinant Vaccines Product Introduction

7.4.4 Bayer AG Response to COVID-19 and Related Developments

7.5 Sanofi S A.

7.5.1 Sanofi S A. Business Overview

7.5.2 Sanofi S A. Recombinant Vaccines Quarterly Production and Revenue, 2020

7.5.3 Sanofi S A. Recombinant Vaccines Product Introduction

7.5.4 Sanofi S A. Response to COVID-19 and Related Developments

7.6 Protein Science Corporation

7.6.1 Protein Science Corporation Business Overview

7.6.2 Protein Science Corporation Recombinant Vaccines Quarterly Production and Revenue, 2020

7.6.3 Protein Science Corporation Recombinant Vaccines Product Introduction

7.6.4 Protein Science Corporation Response to COVID-19 and Related Developments

7.7 GlaxoSmithKline Plc.

7.7.1 GlaxoSmithKline Plc. Business Overview

7.7.2 GlaxoSmithKline Plc. Recombinant Vaccines Quarterly Production and Revenue, 2020

7.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Product Introduction

7.7.4 GlaxoSmithKline Plc. Response to COVID-19 and Related Developments

7.8 Novartis AG

7.8.1 Novartis AG Business Overview

7.8.2 Novartis AG Recombinant Vaccines Quarterly Production and Revenue, 2020

7.8.3 Novartis AG Recombinant Vaccines Product Introduction

7.8.4 Novartis AG Response to COVID-19 and Related Developments

7.9 Bharat Biotech

7.9.1 Bharat Biotech Business Overview

7.9.2 Bharat Biotech Recombinant Vaccines Quarterly Production and Revenue, 2020

7.9.3 Bharat Biotech Recombinant Vaccines Product Introduction

7.9.4 Bharat Biotech Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Recombinant Vaccines Supply Chain Analysis

8.1.1 Recombinant Vaccines Supply Chain Analysis

8.1.2 Covid-19 Impact on Recombinant Vaccines Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Recombinant Vaccines Distribution Channels

8.2.2 Covid-19 Impact on Recombinant Vaccines Distribution Channels

8.2.3 Recombinant Vaccines Distributors

8.3 Recombinant Vaccines Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

FEATURED COMPANIES

Merck& Co. Inc

Green Cross Corporation

Pfizer Inc

Bayer

Sanofi

Protein Science Corporation

List of Tables

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Recombinant Vaccines Assessment

Table 9. COVID-19 Impact: Recombinant Vaccines Market Trends

Table 10. COVID-19 Impact Global Recombinant Vaccines Market Size

Table 11. Global Recombinant Vaccines Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Recombinant Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global Recombinant Vaccines Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Recombinant Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Recombinant Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Recombinant Vaccines Market Growth Drivers

Table 17. Global Recombinant Vaccines Market Restraints

Table 18. Global Recombinant Vaccines Market Opportunities

Table 19. Global Recombinant Vaccines Market Challenges

Table 20. Key Manufacturers Recombinant Vaccines Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Recombinant Vaccines Market Size, 2019 (K Units) & (US$ Million)

Table 22. Recombinant Vaccines Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers Recombinant Vaccines Manufacturing Plants

Table 24. Key Manufacturers Recombinant Vaccines Market Served

Table 25. Date of Key Manufacturers Enter into Recombinant Vaccines Market

Table 26. Key Manufacturers Recombinant Vaccines Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Recombinant Vaccines Market Size by Type, 2020, (US$ Million)

Table 29. Global Recombinant Vaccines Market Size by Type, 2020 (K Units)

Table 30. Global Recombinant Vaccines Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global Recombinant Vaccines Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Recombinant Vaccines Market Size by Application, 2020-2021 (K Units)

Table 33. Global Recombinant Vaccines Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global Recombinant Vaccines Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Recombinant Vaccines Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Recombinant Vaccines Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Recombinant Vaccines Market Size, 2019-2021 (K Units)

Table 38. US Recombinant Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Recombinant Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Recombinant Vaccines Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Recombinant Vaccines Market Size, 2019-2021 (K Units)

Table 43. Germany Recombinant Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Recombinant Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Recombinant Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Recombinant Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Recombinant Vaccines Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Recombinant Vaccines Market Size, 2019-2021 (K Units)

Table 50. China Recombinant Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Recombinant Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Recombinant Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Recombinant Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Recombinant Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Recombinant Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Recombinant Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. Merck & Co., Inc Business Overview

Table 58. Merck & Co., Inc Recombinant Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Merck & Co., Inc Recombinant Vaccines Product

Table 60. Merck & Co., Inc Response to COVID-19 and Related Developments

Table 61. Green Cross Corporation Business Overview

Table 62. Green Cross Corporation Recombinant Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Green Cross Corporation Recombinant Vaccines Product

Table 64. Green Cross Corporation Response to COVID-19 and Related Developments

Table 65. Pfizer Inc. Business Overview

Table 66. Pfizer Inc. Recombinant Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Pfizer Inc. Recombinant Vaccines Product

Table 68. Pfizer Inc. Response to COVID-19 and Related Developments

Table 69. Bayer AG Business Overview

Table 70. Bayer AG Recombinant Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Bayer AG Recombinant Vaccines Product

Table 72. Bayer AG Response to COVID-19 and Related Developments

Table 73. Sanofi S A. Business Overview

Table 74. Sanofi S A. Recombinant Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Sanofi S A. Recombinant Vaccines Product

Table 76. Sanofi S A. Response to COVID-19 and Related Developments

Table 77. Protein Science Corporation Business Overview

Table 78. Protein Science Corporation Recombinant Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Protein Science Corporation Recombinant Vaccines Product

Table 80. Protein Science Corporation Response to COVID-19 and Related Developments

Table 81. GlaxoSmithKline Plc. Business Overview

Table 82. GlaxoSmithKline Plc. Recombinant Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. GlaxoSmithKline Plc. Recombinant Vaccines Product

Table 84. GlaxoSmithKline Plc. Response to COVID-19 and Related Developments

Table 85. Novartis AG Business Overview

Table 86. Novartis AG Recombinant Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Novartis AG Recombinant Vaccines Product

Table 88. Novartis AG Response to COVID-19 and Related Developments

Table 89. Bharat Biotech Business Overview

Table 90. Bharat Biotech Recombinant Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Bharat Biotech Recombinant Vaccines Product

Table 92. Bharat Biotech Response to COVID-19 and Related Developments

Table 93. Recombinant Vaccines Distributors List

Table 94. Recombinant Vaccines Customers List

Table 95. Covid-19 Impact on Recombinant Vaccines Customers

List of Figures

Figure 1. Recombinant Vaccines Product Picture

Figure 2. Recombinant Vaccines Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Recombinant Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Recombinant Vaccines Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Recombinant Vaccines Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Recombinant Vaccines Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Recombinant Vaccines Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Recombinant Vaccines Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Recombinant Vaccines Market Size Market Share, 2019-2021

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3250

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$4875

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6500

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Covid-19 Impact on Recombinant Vaccines Market, Global Research Reports 2020-2021

Published Date: May 2020

Report Code: QYRE-Auto-1R2950

Covid-19 Impact on Recombinant Vaccines Market, Global Research Reports 2020-2021

FEATURED COMPANIES

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-33R12509

Thu May 16 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-17Z15431

Thu May 16 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-36D15165

Thu May 16 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-32R12420

Thu May 16 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions